The aim of our study was to compare the performances of two new hepatitis B virus (HBV) DNA assays, a cross-linking assay (NAXCOR) and a hybrid-capture amplification assay (Digene), versus the widely
P = positive; N = negative; OS = oral swab; Lu = lung; To = tonsil; To = tongue; Ki = Kidney; He = heart; Li = liver; Sp = spleen; ML = mandibular lymph node; Il = ileum; Bl = bladder; NA = neutralizi